Tafenoquine exposure assessment, safety, and relapse prevention efficacy in children with Plasmodium vivax malaria: open-label, single-arm, non-comparative, multicentre, pharmacokinetic bridging, phase 2 trial

The Lancet Child & Adolescent Health ◽

10.1016/s2352-4642(21)00328-x ◽

2021 ◽

Cited By ~ 1

Author(s):

Iván D Vélez ◽

Tran T Hien ◽

Justin A Green ◽

Ana Martin ◽

Hema Sharma ◽

...

Keyword(s):

Plasmodium Vivax ◽

Exposure Assessment ◽

Relapse Prevention ◽

Vivax Malaria ◽

Phase 2 ◽

Open Label ◽

Phase 2 Trial ◽

Plasmodium Vivax Malaria

Download Full-text

Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial

The Lancet Infectious Diseases ◽

10.1016/s1473-3099(15)00320-5 ◽

2016 ◽

Vol 16 (1) ◽

pp. 61-69 ◽

Cited By ~ 95

Author(s):

Aung Pyae Phyo ◽

Podjanee Jittamala ◽

François H Nosten ◽

Sasithon Pukrittayakamee ◽

Mallika Imwong ◽

...

Keyword(s):

Plasmodium Falciparum ◽

Plasmodium Vivax ◽

Vivax Malaria ◽

Antimalarial Activity ◽

Phase 2 ◽

Open Label ◽

Phase 2 Trial ◽

Plasmodium Vivax Malaria ◽

Open Label Phase

Download Full-text

Faculty Opinions recommendation of Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718215510.793497880 ◽

2014 ◽

Author(s):

Carlos Seas

Keyword(s):

Plasmodium Vivax ◽

Relapse Prevention ◽

Vivax Malaria ◽

Dose Selection ◽

Double Blind ◽

Plasmodium Vivax Malaria

Download Full-text

Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study

The Lancet ◽

10.1016/s0140-6736(13)62568-4 ◽

2014 ◽

Vol 383 (9922) ◽

pp. 1049-1058 ◽

Cited By ~ 149

Author(s):

Alejandro Llanos-Cuentas ◽

Marcus V Lacerda ◽

Ronnatrai Rueangweerayut ◽

Srivicha Krudsood ◽

Sandeep K Gupta ◽

...

Keyword(s):

Plasmodium Vivax ◽

Relapse Prevention ◽

Vivax Malaria ◽

Dose Selection ◽

Double Blind ◽

Plasmodium Vivax Malaria

Download Full-text

Faculty Opinions recommendation of Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718215510.793492783 ◽

2014 ◽

Author(s):

Tamar Lachish

Keyword(s):

Plasmodium Vivax ◽

Relapse Prevention ◽

Vivax Malaria ◽

Dose Selection ◽

Double Blind ◽

Plasmodium Vivax Malaria

Download Full-text

Comparison of the safety and efficacy of fixed-dose combination of arterolane maleate and piperaquine phosphate with chloroquine in acute, uncomplicated Plasmodium vivax malaria: a phase III, multicentric, open-label study

Malaria Journal ◽

10.1186/s12936-016-1084-1 ◽

2016 ◽

Vol 15 (1) ◽

Cited By ~ 10

Author(s):

Neena Valecha ◽

Deepali Savargaonkar ◽

Bina Srivastava ◽

B. H. Krishnamoorthy Rao ◽

Santanu K. Tripathi ◽

...

Keyword(s):

Plasmodium Vivax ◽

Vivax Malaria ◽

Phase Iii ◽

Fixed Dose ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy ◽

Plasmodium Vivax Malaria ◽

Dose Combination

Download Full-text

Efficacy of directly-observed chloroquine-primaquine treatment for uncomplicated acute Plasmodium vivax malaria in northeast Myanmar: A prospective open-label efficacy trial

Travel Medicine and Infectious Disease ◽

10.1016/j.tmaid.2019.101499 ◽

2020 ◽

Vol 36 ◽

pp. 101499 ◽

Cited By ~ 4

Author(s):

Shiling Xu ◽

Weilin Zeng ◽

Huguette Gaelle Ngassa Mbenda ◽

Huaie Liu ◽

Xi Chen ◽

...

Keyword(s):

Plasmodium Vivax ◽

Vivax Malaria ◽

Efficacy Trial ◽

Open Label ◽

Plasmodium Vivax Malaria

Download Full-text

Efficacy and safety of artemisinin-based combination therapy and chloroquine with concomitant primaquine to treat Plasmodium vivax malaria in Brazil: an open label randomized clinical trial

Malaria Journal ◽

10.1186/s12936-018-2192-x ◽

2018 ◽

Vol 17 (1) ◽

Cited By ~ 6

Author(s):

André Daher ◽

Dhelio Pereira ◽

Marcus V. G. Lacerda ◽

Márcia A. A. Alexandre ◽

Cristiana T. Nascimento ◽

...

Keyword(s):

Clinical Trial ◽

Combination Therapy ◽

Plasmodium Vivax ◽

Randomized Clinical Trial ◽

Vivax Malaria ◽

Efficacy And Safety ◽

Open Label ◽

Plasmodium Vivax Malaria

Download Full-text

ANALYSIS OF CONGENITAL PLASMODIUM VIVAX MALARIA: A SIX YEAR PROSPECTIVE OBSERVATIONAL STUDY FROM BIKANER, NORTHWESTERN INDIA

10.26226/morressier.58fa1765d462b80290b50fde ◽

2017 ◽

Author(s):

Gajanand Singh Tanwar

Keyword(s):

Observational Study ◽

Plasmodium Vivax ◽

Vivax Malaria ◽

Prospective Observational Study ◽

Northwestern India ◽

Plasmodium Vivax Malaria

Download Full-text

Faculty Opinions recommendation of Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717954976.793462183 ◽

2012 ◽

Author(s):

Mark Faries

Keyword(s):

Advanced Melanoma ◽

Phase 2 ◽

Open Label ◽

Phase 2 Trial

Download Full-text

Faculty Opinions recommendation of Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718020296.793478787 ◽

2013 ◽

Author(s):

Arthur Kim

Keyword(s):

Hepatitis C ◽

Phase 2 ◽

Genotype 1 ◽

Hepatitis C Infection ◽

Open Label ◽

Multicentre Phase ◽

Phase 2 Trial ◽

Treatment Naïve ◽

Peginterferon Alfa ◽

Ns3 Protease

Download Full-text